A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis

NCT05179577 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity

Interventions

DRUG: Arbaclofen
DRUG: Placebo

Sponsor

RVL Pharmaceuticals, Inc.